APA (7th ed.) Citation

Khachaturyan, E. A., Antonova, T. G., Stativko, O. A., & Pokataev, I. A. (2025). Lenvatinib in combination with pembrolizumab as first-line therapy for advanced endometrial cancer: Clinical case. ABV-press.

Chicago Style (17th ed.) Citation

Khachaturyan, E. A., T. G. Antonova, O. A. Stativko, and I. A. Pokataev. Lenvatinib in Combination with Pembrolizumab as First-line Therapy for Advanced Endometrial Cancer: Clinical Case. ABV-press, 2025.

MLA (9th ed.) Citation

Khachaturyan, E. A., et al. Lenvatinib in Combination with Pembrolizumab as First-line Therapy for Advanced Endometrial Cancer: Clinical Case. ABV-press, 2025.